Fanconi Anemia Gene Variants in Patients with Gonadal Dysfunction

被引:12
作者
Daum, Hagit [1 ]
Zlotogora, Joel [2 ,3 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Dept Genet, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Genet, Hadassah Med Org, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
关键词
Fanconi anemia; Gonadal dysfunction; Azoospermia; Primary ovarian insufficiency; Mosaic; Hypomorphic variants; MUTATIONS; CANCER; BRCA2; XRCC2;
D O I
10.1007/s43032-021-00582-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Fanconi anemia (FA) is a multisystem disease, characterized by the triad of physical abnormalities, bone marrow failure, and increased risk for malignancy. In the past few years, data has accumulated regarding fertility issues in FA patients, mostly due to gonadal dysfunction, which is prevalent in FA patients reaching puberty. It seems that attenuated FA phenotype lacking the classical manifestations often is presented with POI or azoospermia. Searching the literature, we summarized data regarding FA patients presenting as suffering from sub/infertility due to gonadal dysfunction, with or without other FA symptoms. We present a summary of the patients having biallelic pathogenic variants in FA genes FANCA, FANCM, BRCA2, and XRCC2 that presented with gonadal dysfunction with or without other phenotypic features of FA. Some were in mosaic, while some are considered hypomorphic, enabling residual protein function. There are also a few descriptions of POI associated with monoallelic pathogenic variants in FANCA, BRCA2, and FANCL. We conclude that the diagnosis of FA in gonadal dysfunction patients is of utmost importance due to its actionability. Follow-up strategies in FA patients are designed to discover early stages of leukemias and solid tumors and thus save lives. The feasibility of next-generation sequencing (NGS) can now ease this diagnostic procedure. An open question is the justification of performing NGS for all isolated azoospermia/POI patients.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 50 条
[21]   Induced Pluripotency and Gene Editing in Fanconi Anemia [J].
Navarro, Susana ;
Giorgetti, Alessandra ;
Raya, Angel ;
Tolar, Jakub .
CURRENT GENE THERAPY, 2016, 16 (05) :321-328
[22]   Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes [J].
Flynn, Elizabeth K. ;
Kamat, Aparna ;
Lach, Francis P. ;
Donovan, Frank X. ;
Kimble, Danielle C. ;
Narisu, Narisu ;
Sanborn, Erica ;
Boulad, Farid ;
Davies, Stella M. ;
Gillio, Alfred P., III ;
Harris, Richard E. ;
MacMillan, Margaret L. ;
Wagner, John E. ;
Smogorzewska, Agata ;
Auerbach, Arleen D. ;
Ostrander, Elaine A. ;
Chandrasekharappa, Settara C. .
HUMAN MUTATION, 2014, 35 (11) :1342-1353
[23]   Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients [J].
Nakamura, A ;
Matsuura, S ;
Tauchi, H ;
Hanada, R ;
Ohashi, H ;
Hasegawa, T ;
Honda, K ;
Masuno, M ;
Imaizumi, K ;
Sugita, K ;
Ide, T ;
Komatsu, K .
JOURNAL OF HUMAN GENETICS, 1999, 44 (01) :48-51
[24]   Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi Registry [J].
Tsur, Nir ;
Frig, Omri ;
Steinberg-Shemer, Orna ;
Tamary, Hannah ;
Kurman, Noga ;
Mizrachi, Aviram ;
Popovtzer, Aron .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (08) :491-496
[25]   Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles [J].
Osorio, Ana ;
Bogliolo, Massimo ;
Fernandez, Victoria ;
Barroso, Alicia ;
de la Hoya, Miguel ;
Caldes, Trinidad ;
Lasa, Adriana ;
Ramon y Cajal, Teresa ;
Santamarina, Marta ;
Vega, Ana ;
Quiles, Francisco ;
Lazaro, Conxi ;
Diez, Orland ;
Fernandez, Daniel ;
Gonzalez-Sarmiento, Rogelio ;
Duran, Mercedes ;
Fernandez Piqueras, Jose ;
Marin, Maria ;
Pujol, Roser ;
Surralles, Jordi ;
Benitez, Javier .
HUMAN MUTATION, 2013, 34 (12) :1615-1618
[26]   Diagnosis of Fanconi anemia in patients without congenital malformations: An international Fanconi anemia registry study [J].
Giampietro, PF ;
Verlander, PC ;
Davis, JG ;
Auerbach, AD .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 68 (01) :58-61
[27]   Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients [J].
Ghazwani, Yahya ;
AlBalwi, Mohammed ;
Al-Abdulkareem, Ibrahim ;
Al-Dress, Mohammed ;
Alharbi, Talal ;
Alsudairy, Reem ;
Alomari, Ali ;
Aljamaan, Khalid ;
Essa, Mohammed ;
Al-Zahrani, Mohsen ;
Alsultan, Abdulrahman .
CANCER GENETICS, 2016, 209 (04) :171-176
[28]   Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience [J].
Altay, C ;
Alikasifoglu, M ;
Kara, A ;
Tuncbilek, E ;
Ozbek, N ;
SchroederKurth, TM .
CLINICAL GENETICS, 1997, 51 (05) :296-302
[29]   The molecular biology of Fanconi anemia [J].
Tamary, H ;
Bar-Yam, R ;
Zemach, M ;
Dgany, O ;
Shalmon, L ;
Yaniv, I .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (10) :819-823
[30]   Targeted gene therapy and cell reprogramming in Fanconi anemia [J].
Rio, Paula ;
Banos, Rocio ;
Lombardo, Angelo ;
Quintana-Bustamante, Oscar ;
Alvarez, Lara ;
Garate, Zita ;
Genovese, Pietro ;
Almarza, Elena ;
Valeri, Antonio ;
Diez, Begona ;
Navarro, Susana ;
Torres, Yaima ;
Trujillo, Juan P. ;
Murillas, Rodolfo ;
Segovia, Jose C. ;
Samper, Enrique ;
Surralles, Jordi ;
Gregory, Philip D. ;
Holmes, Michael C. ;
Naldini, Luigi ;
Bueren, Juan A. .
EMBO MOLECULAR MEDICINE, 2014, 6 (06) :835-848